Quick Answer
Keros Therapeutics, Inc. reported Total Assets of $338.02 million for fiscal year 2025.
Keros Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $338.02M | -45.1% |
| 2024 | $615.89M | +66.4% |
| 2023 | $370.02M | +20.6% |
| 2022 | $306.78M | +20.2% |
| 2021 | $255.25M | -5.3% |
| 2020 | $269.44M | +2359.5% |
| 2019 | $10.96M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $742.78M | +28.2% | -1.9% |
| June 30, 2025 | $757.16M | +66.4% | -3.5% |
| March 31, 2025 | $784.56M | +61.5% | +27.4% |
| December 31, 2024 | $615.89M | +66.4% | +6.3% |
| September 30, 2024 | $579.27M | +77.6% | +27.3% |
| June 30, 2024 | $455.02M | +27.7% | -6.3% |
| March 31, 2024 | $485.82M | +26.4% | +31.3% |
| December 31, 2023 | $370.02M | +20.6% | +13.4% |
- Keros Therapeutics, Inc. showed a decrease of -45.1% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Keros Therapeutics, Inc.’s total assets has grown by 2985.5% (from $10.96 million to $338.02 million).
- The most recent figure is from Keros Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: